Organogenesis Holdings Inc (ORGO) Directors and Executive Officers

Officers & Directors

Executives:

1. Gary S. Gillheeney, Sr.
Chief Executive Officer, President, and Chair of the Board of Directors

2. David Francisco
Chief Financial Officer (Principal Financial and Accounting Officer)

Directors:

1. Robert Ades
Director

2. Michael J. Driscoll
Director

3. Prathyusha Duraibabu
Director

4. Michele Korfin
Director

5. David Erani
Director

6. Gilberto Quintero
Director

7. Glenn H. Nussdorf
Director

8. Jon Giacomin
Director

9. Arthur S. Leibowitz
Director

10. Alan A. Ades
Director

11. Gary S. Gillheeney, Sr.
Director ,

Organogenesis Holdings Inc currently has 854 employees.

News about Organogenesis Holdings Inc Key Personnel

Organogenesis Navigates Funding Gaps and Policy Shifts Amidst Record High Revenue: A Dual Focus on Growth and Patient-Centric Solutions

In an era where healthcare innovation is paramount, Organogenesis Holdings Inc. finds itself at a critical crossroads. As the company pushes for a delay in the Centers for Medicare and Medicaid Services (CMS) Local Coverage Determination (LCD) implementation, it seeks to bolster its commitment to patient access and the strength of medical evidence supporting its treatments. However, this advocacy comes against the backdrop of a significant financial struggle that raises questions about the firm’s sustainability and future in a competitive landscape. A Shift in Coverage and Payment Policy Organogenesis, a company specializing in regenerative medicine, has advocated for “an integrated coverage and payment...